The DOI matches its Crossref record; 86 of the 86 references it cites were found in a registry or an index.
Myasthenia gravis: A comprehensive review of immune dysregulation and etiological mechanisms
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2008) · doi:10.1038/nrg2290 · Cited by 5,199
The complex role of estrogens in inflammation
Straub, R. H. (2007) · Endocrine Reviews · doi:10.1210/er.2007-0001 · Cited by 1,950
The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses
Boone, D. L., Turer, E. E., Lee, E. G., Ahmad, R.-C., Wheeler, M. T., Tsui, C., Hurley, P., Chien, M., Chai, S., Hitotsumatsu, O., et al. (2004) · Nature Immunology · doi:10.1038/ni1110 · Cited by 1,090
MicroRNAs: new regulators of immune cell development and function
Baltimore, D., Boldin, M. P., O'Connell, R. M., Rao, D. S., & Taganov, K. D. (2008) · Nature Immunology · doi:10.1038/ni.f.209 · Cited by 1,088
Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self
Derbinski, J., Schulte, A., Kyewski, B., & Klein, L. (2001) · Nature Immunology · doi:10.1038/ni723 · Cited by 1,077
The Receptor Tyrosine Kinase MuSK Is Required for Neuromuscular Junction Formation In Vivo
DeChiara, T. M., Bowen, D. C., Valenzuela, D. M., Simmons, M. V., Poueymirou, W. T., Thomas, S., Kinetz, E., Compton, D. L., Rojas, E., Park, J. S., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81251-9 · Cited by 913
Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity
Meriggioli, M. N., & Sanders, D. B. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70063-8 · Cited by 894
Legler, D. F., Loetscher, M., Roos, R. S., Clark-Lewis, I., Baggiolini, M., & Moser, B. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.4.655 · Cited by 837
Mechanisms of impaired regulation by CD4+CD25+FOXP3+ regulatory T cells in human autoimmune diseases
Buckner, J. H. (2010) · Nature Reviews Immunology · doi:10.1038/nri2889 · Cited by 789
A systematic review of population based epidemiological studies in Myasthenia Gravis
Carr, A. S., Cardwell, C. R., McCarron, P. O., & McConville, J. (2010) · BMC Neurology · doi:10.1186/1471-2377-10-46 · Cited by 756
Tang, Y., Luo, X., Cui, H., Ni, X., Yuan, M., Guo, Y., Huang, X., Zhou, H., de Vries, N., Tak, P. P., et al. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24436 · Cited by 735
Lrp4 is a receptor for Agrin and forms a complex with MuSK
Kim, N., Stiegler, A. L., Cameron, T. O., Hallock, P. T., Gomez, A. M., Huang, J. H., Hubbard, S. R., Dustin, M. L., & Burden, S. J. (2008) · Cell · doi:10.1016/j.cell.2008.10.002 · Cited by 676 · cited 14×
“The LRP4 protein belongs to a family of proteins that has been recently identified as the receptor for the neural agrin that can activate MuSK [28].”
BackgroundInfluentialMicroRNA-21 Is Up-Regulated in Allergic Airway Inflammation and Regulates IL-12p35 Expression
Lu, T. X., Munitz, A., & Rothenberg, M. E. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803560 · Cited by 570
Distinct roles of nerve and muscle in postsynaptic differentiation of the neuromuscular synapse
Lin, W., Burgess, R. W., Dominguez, B., Pfaff, S. L., Sanes, J. R., & Lee, K.-F. (2001) · Nature · doi:10.1038/35074025 · Cited by 535
Autoantibodies to low‐density lipoprotein receptor–related protein 4 in myasthenia gravis
Higuchi, O., Hamuro, J., Motomura, M., & Yamanashi, Y. (2011) · Annals of Neurology · doi:10.1002/ana.22312 · Cited by 535
IgG1 antibodies to acetylcholine receptors in ‘seronegative’ myasthenia gravis†
Leite, M. I., Jacob, S., Viegas, S., Cossins, J., Clover, L., Morgan, B. P., Beeson, D., Willcox, N., & Vincent, A. (2008) · Brain · doi:10.1093/brain/awn092 · Cited by 527
Luther, S. A., Lopez, T., Bai, W., Hanahan, D., & Cyster, J. G. (2000) · Immunity · doi:10.1016/s1074-7613(00)80199-5 · Cited by 468
The influence of sex and gender on the immune response
Oertelt-Prigione, S. (2012) · Autoimmunity Reviews · doi:10.1016/j.autrev.2011.11.022 · Cited by 459 · cited 1×
“Relevant studies have focused on the impact of these hormones on cytokine production by different effector cells and on immunoglobulin production by B lymphocytes [115].”
BackgroundTzartos, S. J., & Lindstrom, J. M. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.2.755 · Cited by 450
Balandina, A., Lécart, S., Dartevelle, P., Saoudi, A., & Berrih-Aknin, S. (2005) · Blood · doi:10.1182/blood-2003-11-3900 · Cited by 429
Self-citationInduction of regulatory T cells by physiological level estrogen
Tai, P., Wang, J., Jin, H., Song, X., Yan, J., Kang, Y., Zhao, L., An, X., Du, X., Chen, X., et al. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21221 · Cited by 358
Serum Levels of microRNAs in Patients with Heart Failure
Goren, Y., Kushnir, M., Zafrir, B., Tabak, S., Lewis, B. S., & Amir, O. (2012) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfr155 · Cited by 354
The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes
Marx, A., Pfister, F., Schalke, B., Saruhan-Direskeneli, G., Melms, A., & Ströbel, P. (2013) · Autoimmunity Reviews · doi:10.1016/j.autrev.2013.03.007 · Cited by 351
Tzartos, J. S. (2012) · Archives of Neurology · doi:10.1001/archneurol.2011.2393 · Cited by 342
Zisimopoulou, P., Evangelakou, P., Tzartos, J., Lazaridis, K., Zouvelou, V., Mantegazza, R., Antozzi, C., Andreetta, F., Evoli, A., Deymeer, F., et al. (2014) · Journal of Autoimmunity · doi:10.1016/j.jaut.2013.12.004 · Cited by 329
Self-citationIwakiri, D., Zhou, L., Samanta, M., Matsumoto, M., Ebihara, T., Seya, T., Imai, S., Fujieda, M., Kawa, K., & Takada, K. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20081761 · Cited by 309
The Thymus Is a Common Target Organ in Infectious Diseases
Savino, W. (2006) · PLoS Pathogens · doi:10.1371/journal.ppat.0020062 · Cited by 296
Control of Autoimmunity by Naturally Arising Regulatory CD4+ T Cells
(2003) · Advances in Immunology · doi:10.1016/s0065-2776(03)81008-8 · Cited by 283
Circulating MicroRNAs as biomarkers for disease staging in multiple sclerosis
Gandhi, R., Healy, B., Gholipour, T., Egorova, S., Musallam, A., Hussain, M. S., Nejad, P., Patel, B., Hei, H., Khoury, S., et al. (2013) · Annals of Neurology · doi:10.1002/ana.23880 · Cited by 258
Drayton, D. L., Ying, X., Lee, J., Lesslauer, W., & Ruddle, N. H. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021761 · Cited by 251
Klooster, R., Plomp, J. J., Huijbers, M. G., Niks, E. H., Straasheijm, K. R., Detmers, F. J., Hermans, P. W., Sleijpen, K., Verrips, A., Losen, M., et al. (2012) · Brain · doi:10.1093/brain/aws025 · Cited by 218
Meloni, A., Furcas, M., Cetani, F., Marcocci, C., Falorni, A., Perniola, R., Pura, M., Bøe Wolff, A. S., Husebye, E. S., Lilic, D., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0935 · Cited by 209
MEAGER, A., WADHWA, M., DILGER, P., BIRD, C., THORPE, R., NEWSOM-DAVIS, J., & WILLCOX, N. (2003) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.2003.02113.x · Cited by 198
Estrogen receptor alpha is necessary in thymic development and estradiol-induced thymic alterations.
Staples, J. E., Gasiewicz, T. A., Fiore, N. C., Lubahn, D. B., Korach, K. S., & Silverstone, A. E. (1999) · PubMed · Cited by 184
The chemokine CXCL13 is a key molecule in autoimmune myasthenia gravis
Meraouna, A., Cizeron-Clairac, G., Panse, R. L., Bismuth, J., Truffault, F., Tallaksen, C., & Berrih-Aknin, S. (2006) · Blood · doi:10.1182/blood-2005-06-2383 · Cited by 172
Self-citationCharacterization of Early Stages of Human B Cell Development by Gene Expression Profiling
Hystad, M. E., Myklebust, J. H., Bø, T. H., Sivertsen, E. A., Rian, E., Forfang, L., Munthe, E., Rosenwald, A., Chiorazzi, M., Jonassen, I., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.6.3662 · Cited by 168
Risk for myasthenia gravis maps to a 151 Pro→Ala change in TNIP1 and to human leukocyte antigen‐B*08
Gregersen, P. K., Kosoy, R., Lee, A. T., Lamb, J., Sussman, J., McKee, D., Simpfendorfer, K. R., Pirskanen‐Matell, R., Piehl, F., Pan‐Hammarstrom, Q., et al. (2012) · Annals of Neurology · doi:10.1002/ana.23691 · Cited by 168
An Essential Role for Thymic Mesenchyme in Early T Cell Development
Suniara, R. K., Jenkinson, E. J., & Owen, J. J. T. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.6.1051 · Cited by 164
Polyubiquitin binding to ABIN1 is required to prevent autoimmunity
Nanda, S. K., Venigalla, R. K. C., Ordureau, A., Patterson-Kane, J. C., Powell, D. W., Toth, R., C. Arthur, J. S., & Cohen, P. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20102177 · Cited by 160
Estrogen Receptor α Is Necessary in Thymic Development and Estradiol-Induced Thymic Alterations
Staples, J. E., Gasiewicz, T. A., Fiore, N. C., Lubahn, D. B., Korach, K. S., & Silverstone, A. E. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.8.4168 · Cited by 159
Gradolatto, A., Nazzal, D., Truffault, F., Bismuth, J., Fadel, É., Foti, M., & Berrih‐Aknin, S. (2014) · Journal of Autoimmunity · doi:10.1016/j.jaut.2013.12.015 · Cited by 158
Self-citationAlsaleh, G., Suffert, G., Semaan, N., Juncker, T., Frenzel, L., Gottenberg, J., Sibilia, J., Pfeffer, S., & Wachsmann, D. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0801613 · Cited by 156
Genetic basis of myasthenia gravis – A comprehensive review
Avidan, N., Panse, R. L., Berrih‐Aknin, S., & Miller, A. (2013) · Journal of Autoimmunity · doi:10.1016/j.jaut.2013.12.001 · Cited by 148
Self-citationEpidemiology of Myasthenia Gravis in Denmark A Longitudinal and Comprehensive Population Survey
Somnier, F., Keiding, N., & Paulson, O. B. (1991) · Archives of Neurology · doi:10.1001/archneur.1991.00530190081019 · Cited by 136
Epstein‐Barr virus persistence and reactivation in myasthenia gravis thymus
Cavalcante, P., Serafini, B., Rosicarelli, B., Maggi, L., Barberis, M. C. P., Antozzi, C. G., Berrih‐Aknin, S., Bernasconi, P., Aloisi, F., & Mantegazza, R. (2009) · Annals of Neurology · doi:10.1002/ana.21902 · Cited by 134
Self-citationDelpy, L., Douin‐Echinard, V., Garidou, L., Bruand, C., Saoudi, A., & Guéry, J. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.8.5050 · Cited by 130
Confirmation of TNIP1 and IL23A as susceptibility loci for psoriatic arthritis
Bowes, J., Orozco, G., Flynn, E., Ho, P., Brier, R., Marzo‐Ortega, H., Coates, L. C., McManus, R., Ryan, A. W., Kane, D. J., et al. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2011.150102 · Cited by 126
Masuda, M., Matsumoto, M., Tanaka, S., Nakajima, K., Yamada, N., 井戸, 信., Ohtsuka, T., Nishida, M., Hirano, T., & Utsumi, H. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.03.016 · Cited by 118
Genetic Factors in Autoimmune Myasthenia Gravis
Giraud, M., Vandiedonck, C., & Garchon, H. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1405.027 · Cited by 116
Effects of Cytokines on Acetylcholine Receptor Expression: Implications for Myasthenia Gravis
Poëa‐Guyon, S., Christadoss, P., Panse, R. L., Guyon, T., Baets, M. H. D., Wakkach, A., Bidault, J., Tzartos, S. J., & Berrih‐Aknin, S. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.10.5941 · Cited by 108
Self-citationThe search for new antigenic targets in myasthenia gravis
Cossins, J., Belaya, K., Zoltowska, K. M., Koneczny, I., Maxwell, S., Jacobson, L. W., Leite, M. I., Waters, P. J., Vincent, A. C., & Beeson, D. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06833.x · Cited by 106
Luo, C., Li, Y., Liu, W., Feng, H., Wang, H., Huang, X., Li, Q., & Ouyang, J. (2013) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2012.12.001 · Cited by 103
Let-7/miR-98 regulate Fas and Fas-mediated apoptosis
Wang, S., Tang, Y., Cui, H., Zhao, X., Luo, X., Pan, W. Q., Huang, X., & Shen, N. (2011) · Genes and Immunity · doi:10.1038/gene.2010.53 · Cited by 101
Etiology of myasthenia gravis: Innate immunity signature in pathological thymus
Cavalcante, P., Cufi, P., Mantegazza, R., Berrih‐Aknin, S., Bernasconi, P., & Panse, R. L. (2013) · Autoimmunity Reviews · doi:10.1016/j.autrev.2013.03.010 · Cited by 99
Self-citationShim, G.-J., Kis, L. L., Warner, M. N., & Gustafsson, J.-Α. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307915100 · Cited by 99
Functional defect in regulatory T cells in myasthenia gravis
Thiruppathi, M., Rowin, J., Jiang, Q. L., Sheng, J. R., Prabhakar, B. S., & Meriggioli, M. N. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06840.x · Cited by 97
Overexpression of IFN-Induced Protein 10 and Its Receptor CXCR3 in Myasthenia Gravis
Feferman, T., Maiti, P. K., Berrih‐Aknin, S., Bismuth, J., Bidault, J., Fuchs, S., & Souroujon, M. C. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.9.5324 · Cited by 93
Self-citationLuther, C., Adamopoulou, E., Stoeckle, C., Brucklacher-Waldert, V., Rosenkranz, D., Stoltze, L., Lauer, S., Poeschel, S., Melms, A., & Tolosa, E. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802046 · Cited by 93 · cited 1×
“This result was also observed using peripheral blood cells [77,78].”
ResultCentral role of interferon-beta in thymic events leading to myasthenia gravis
Cufi, P., Dragin, N., Ruhlmann, N., Weiss, J. M., Fadel, É., Serraf, A. E., Berrih‐Aknin, S., & Panse, R. L. (2014) · Journal of Autoimmunity · doi:10.1016/j.jaut.2013.12.016 · Cited by 93
Self-citationMuscle-selective synaptic disassembly and reorganization in MuSK antibody positive MG mice
Punga, A. R., Lin, S., Oliveri, F., Meinen, S., & Rüegg, M. A. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.04.018 · Cited by 90
Implication of double‐stranded RNA signaling in the etiology of autoimmune myasthenia gravis
Cufi, P., Dragin, N., Weiss, J. M., Martínez‐Martínez, P., Baets, M. H. D., Roussin, R., Fadel, É., Berrih‐Aknin, S., & Panse, R. L. (2012) · Annals of Neurology · doi:10.1002/ana.23791 · Cited by 89
Self-citationT Helper Type 17 Cells Expand in Patients with Myasthenia‐Associated Thymoma
Wang, Z., Wang, W., Chen, Y., & Wei, D. (2012) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2012.02703.x · Cited by 86
Altered expression of chemokine receptor CXCR5 on T cells of myasthenia gravis patients
Saito, R., Onodera, H., Tago, H., Suzuki, Y. A., Shimizu, M., Matsumura, Y., Kondo, T., & Itoyama, Y. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.09.001 · Cited by 83
Cai, Y., Zhou, J., & Webb, D. C. (2012) · International Archives of Allergy and Immunology · doi:10.1159/000331437 · Cited by 83
Thymic remodeling associated with hyperplasia in myasthenia gravis
Panse, R. L., Bismuth, J., Cizeron-Clairac, G., Weiss, J. M., Cufi, P., Dartevelle, P., de Rosbo, N. K., & Berrih‐Aknin, S. (2010) · Autoimmunity · doi:10.3109/08916930903563491 · Cited by 82
Self-citationCheng, Z., Qiu, S., Jiang, L., Zhang, A., Bao, W., Liu, P., & Liu, J. (2012) · Journal of Clinical Immunology · doi:10.1007/s10875-012-9834-5 · Cited by 76
Detection of poliovirus-infected macrophages in thymus of patients with myasthenia gravis
Cavalcante, P., Barberis, M. C. P., Cannone, M., Baggi, F., Antozzi, C. G., Maggi, L., Cornelio, F., Barbi, M., Didò, P., Berrih‐Aknin, S., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181d7d884 · Cited by 76
Self-citationMyasthenia gravis patients with ryanodine receptor antibodies have distinctive clinical features
Romi, F. R., Aarli, J. A., & Gilhus, N. E. (2007) · European Journal of Neurology · doi:10.1111/j.1468-1331.2007.01785.x · Cited by 75
Panse, R. L., Cizeron-Clairac, G., Bismuth, J., & Berrih‐Aknin, S. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.11.7868 · Cited by 73
Self-citationWeiss, J. M., Cufi, P., Bismuth, J., Eymard, B., Fadel, É., Berrih‐Aknin, S., & Panse, R. L. (2012) · Immunobiology · doi:10.1016/j.imbio.2012.05.006 · Cited by 72
Self-citationCordiglieri, C., Marolda, R., Franzi, S., Cappelletti, C., Giardina, C., Motta, T., Baggi, F., Bernasconi, P., Mantegazza, R., & Cavalcante, P. (2014) · Journal of Autoimmunity · doi:10.1016/j.jaut.2013.12.013 · Cited by 71
Guyon, T., Wakkach, A., Poëa‐Guyon, S., Mouly, V., Klingel-Schmitt, I., Levasseur, P., Beeson, D., Asher, O., Tzartos, S. J., & Berrih‐Aknin, S. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1248 · Cited by 67
Self-citationBernasconi, P., Barberis, M. C. P., Baggi, F., Passerini, L., Cannone, M., Arnoldi, E., Novellino, L., Cornelio, F., & Mantegazza, R. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62960-4 · Cited by 67
Guyon, T., Levasseur, P., Truffault, F., Cottin, C., Gaud, C., & Berrih‐Aknin, S. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117302 · Cited by 65
Self-citationJiang, L., Cheng, Z., Qiu, S., Que, Z., Bao, W., Jiang, C. Q., Zou, F., Liu, P., & Liu, J. (2012) · International Immunopharmacology · doi:10.1016/j.intimp.2012.07.003 · Cited by 64
Myasthenia gravis during interferon alfa therapy
Batocchi, A. P., Evoli, A., Servidei, S., Palmisani, M. T., Apollo, F., & Tonali, P. (1995) · Neurology · doi:10.1212/wnl.45.2.382 · Cited by 64
Utilizing Twins Concordance Rates to Infer the Predisposition to Myasthenia Gravis
Ramanujam, R., Pirskanen, R., Ramanujam, S., & Hammarström, L. L. G. (2011) · Twin Research and Human Genetics · doi:10.1375/twin.14.2.129 · Cited by 62
Autoimmune myasthenia gravis: autoantibody mechanisms and new developments on immune regulation
Panse, R. L., & Berrih‐Aknin, S. (2013) · Current Opinion in Neurology · doi:10.1097/wco.0b013e328364d6cd · Cited by 56
Self-citationThymoma-associated myasthenia gravis: On the search for a pathogen signature
Cufi, P., Soussan, P., Truffault, F., Fetouchi, R., Robinet, M., Fadel, É., Berrih‐Aknin, S., & Panse, R. L. (2014) · Journal of Autoimmunity · doi:10.1016/j.jaut.2013.12.018 · Cited by 50
Self-citationGlucocorticoid Independence of Acute Thymic Involution Induced by Lymphotoxin and Estrogen
Hirahara, H., Ogawa, M., Kimura, M., et al. (1994) · Cellular Immunology · doi:10.1006/cimm.1994.1038 · Cited by 44
Defects of immunoregulatory mechanisms in myasthenia gravis: role of IL‐17
Gradolatto, A., Nazzal, D., Foti, M., Bismuth, J., Truffault, F., Panse, R. L., & Berrih‐Aknin, S. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06791.x · Cited by 42
Self-citationEymard, B., Garabedian, B. V.-D., Berrih‐Aknin, S., et al. (1991) · Journal of Autoimmunity · doi:10.1016/0896-8411(91)90017-7 · Cited by 41
Self-citationPossible Involvement of Toll-Like Receptors in the Pathogenesis of Myasthenia Gravis
Wang, Y., Yan, M., Tian, F., Zhang, J., Liu, Q., Yang, H., Zhou, W.-B., & Li, J. (2012) · Inflammation · doi:10.1007/s10753-012-9526-6 · Cited by 39
A candidate gene for autoimmune myasthenia gravis
Landouré, G., Knight, M. A., Stanescu, H. C., Taye, A. A., Shi, Y., Diallo, O., Johnson, J. O., Hernandez, D. G., Traynor, B. J., Biesecker, L. G., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e318260cbd0 · Cited by 26
Aimé, C., Cohen‐Kaminsky, S., & Berrih‐Aknin, S. (1991) · Journal of Clinical Immunology · doi:10.1007/bf00918185 · Cited by 19
Self-citationZhang, J., Chen, Y., Shao, Y., Wu, Q., Guan, M., Zhang, W., Wan, J., & Yu, B. (2012) · Autoimmune Diseases · doi:10.1155/2012/265823 · Cited by 7
Cited by
Gilhus, N. E., Tzartos, S., Evoli, A., Palace, J., Burns, T. M., & Verschuuren, J. J. G. M. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0079-y · Cited by 953
Mechanisms of Autoantibody-Induced Pathology
Ludwig, R. J., Vanhoorelbeke, K., Leypoldt, F., Kaya, Z., Bieber, K., McLachlan, S. M., Komorowski, L., Luo, J., Cabral-Marques, O., Hammers, C. M., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00603 · Cited by 469
Lazaridis, K., & Tzartos, S. J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00212 · Cited by 287
Caforio, A. L. P., Adler, Y., Agostini, C., Allanore, Y., Anastasakis, A., Arad, M., Böhm, M., Charron, P., Elliott, P. M., Eriksson, U., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx321 · Cited by 263
Targeting the Neonatal Fc Receptor in Autoimmune Diseases: Pipeline and Progress
Gjølberg, T. T., Mester, S., Calamera, G., Telstad, J. S., Sandlie, I., & Andersen, J. T. (2025) · BioDrugs · doi:10.1007/s40259-025-00708-2 · Cited by 20
Metadata
- Authors
- Berrih-Aknin, S., & Le Panse, R.
- Venue
- Journal of Autoimmunity
- Publisher
- Elsevier BV
- Published
- 2014-08
- Volume
- 52
- Pages
- 90-100
- ISSN
- 0896-8411 (ISSN-L)
- OpenAlex
- W2042968563
- Cited by
- 383
- References
- 86
- FWCI
- 20.57
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.